Biotechnology
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

$37.5M

Market Cap • 12/26/2024

2002

(22 years)
Founded

2011

(13 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Princeton

Headquarters • New Jersey